The Task Force on the Control and Accountability of Prescription Medications met October 26-27, 2011. This task force was established in response to Resolution 107-3-11, Control and Accountability of Prescription Medications, which was approved by the NABP membership at the Association’s 107th Annual Meeting in May 2011.
Task force members reviewed their charge and accepted it as follows:
- Review existing state laws and regulations addressing the control and accountability of prescription drugs, the Report of the Task Force to Review and Recommend Revisions to the Controlled Substances Act, as well as relevant sections of the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act).
- Recommend revisions, if necessary, to the Model Act addressing this issue.
View the committee’s recommendations in the full report (PDF).